vorinostat has been researched along with Cholestasis, Intrahepatic in 1 studies
Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).
Cholestasis, Intrahepatic: Impairment of bile flow due to injury to the HEPATOCYTES; BILE CANALICULI; or the intrahepatic bile ducts (BILE DUCTS, INTRAHEPATIC).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| van der Woerd, WL | 1 |
| Wichers, CG | 1 |
| Vestergaard, AL | 1 |
| Andersen, JP | 1 |
| Paulusma, CC | 1 |
| Houwen, RH | 1 |
| van de Graaf, SF | 1 |
1 other study available for vorinostat and Cholestasis, Intrahepatic
| Article | Year |
|---|---|
Rescue of defective ATP8B1 trafficking by CFTR correctors as a therapeutic strategy for familial intrahepatic cholestasis.
Topics: Adenosine Triphosphatases; Cell Line, Tumor; Cell Polarity; Cholestasis, Intrahepatic; Cystic Fibros | 2016 |